Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Diurnal and National Institutes of Health's CRADA extended

Aug. 6, 2015

Antares Pharma starts phase III trial of subcutaneous testosterone in hypogonadism

Aug. 6, 2015

Cadila Healthcare reports development of lipid lowering agents

Aug. 6, 2015

Lilly reports FFAR1 agonists

Aug. 6, 2015

Lilly designs FFAR1 agonists

Aug. 5, 2015

biOasis's MTfp-I2S effective in mouse model of Hunter syndrome

Aug. 4, 2015

Bristol-Myers Squibb patents lipase inhibitors

Aug. 4, 2015

KT&G Life Sciences develops NQO1 modulators

Aug. 3, 2015

GI Dynamics ends pivotal U.S. trial of EndoBarrier

July 31, 2015

Ascendis Pharma reports topline results from a phase II pediatric study of TransCon Growth Hormone

July 31, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 6, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Infinimmune presents preclinical data on anti-IL-22 antibody for atopic dermatitis
BioWorld Science
Infinimmune Inc. has recently presented results at the annual American Academy of Dermatology conference regarding their anti-IL-22 antibody IFX-101 for the...